Literature DB >> 779597

Vitamin K and the oral anticoagulant drugs.

R A O'Reilly.   

Abstract

The evolution of vitamin K, from a dietary deficiency in birds to a postribosomal modifier of prothrombin in man, has been a fascinating scientific saga. Its antivitamin, the oral anticoagulant drugs, has been a powerful probe both of vitamin K action and of drug interactions. These agents have emerged from a limbo of clinical therapeutics to become a light of human pharmacology.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 779597     DOI: 10.1146/annurev.me.27.020176.001333

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  14 in total

Review 1.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Plasma disposition of vitamin K1 in relation to anticoagulant poisoning.

Authors:  B K Park; A K Scott; A C Wilson; B P Haynes; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

Review 3.  Topical issues in venous thromboembolism.

Authors:  José Ignacio Abad Rico; Juan Vicente Llau Pitarch; José Antonio Páramo Fernández
Journal:  Drugs       Date:  2010-12-14       Impact factor: 9.546

Review 4.  Pharmacokinetic optimisation of the treatment of deep vein thrombosis.

Authors:  A Iorio; G Agnelli
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

5.  Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial).

Authors:  Tetz C Lee; Min Qian; Gregory Y H Lip; Marco R Di Tullio; Susan Graham; Douglas L Mann; Koki Nakanishi; John R Teerlink; Ronald S Freudenberger; Ralph L Sacco; J P Mohr; Arthur J Labovitz; Piotr Ponikowski; Dirk J Lok; Conrado Estol; Stefan D Anker; Patrick M Pullicino; Richard Buchsbaum; Bruce Levin; John L P Thompson; Shunichi Homma; Siqin Ye
Journal:  Am J Cardiol       Date:  2018-06-04       Impact factor: 2.778

6.  Impact of preemptive warfarin dose reduction on anticoagulation after initiation of trimethoprim-sulfamethoxazole or levofloxacin.

Authors:  Abrar Ahmed; John C Stephens; Carol A Kaus; William P Fay
Journal:  J Thromb Thrombolysis       Date:  2007-11-06       Impact factor: 2.300

Review 7.  Anticoagulation therapy in children.

Authors:  Milind D Ronghe; Christina Halsey; Nicholas J Goulden
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

8.  Warfarin poisoning and vitamin K antagonism in rat and human liver. Design of a system in vitro that mimics the situation in vivo.

Authors:  R Wallin; L F Martin
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

Review 9.  The vitamin K-dependent carboxylation reaction.

Authors:  C Vermeer
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

Review 10.  Clinical pharmacokinetics of oral anticoagulants.

Authors:  J G Kelly; K O'Malley
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.